• About us
    • Successful cases
    • R+D
    • Clients
    • News
  • Particle
    technologies
  • Particle characterization
    • Services
      • Development and validation of PSD methods
      • Determination of accuracy of PSD methods
      • Particle morphological characterization
      • Solid state and crystallographic studies
      • Nano-Characterization
      • Analytical Development
    • Analysis
      • Granulometry - PSD
        • Laser Diffraction
        • Automated Optical Microscopy
      • Particle Morphology
        • Automated Optical Microscopy
        • Electron Microscopy
      • Nanoparticle Analysis
        • Dynamic Light Scattering
        • CRYO-TEM
      • Chemical Composition
        • HPLC (High-Performance Liquid Chromatography)
        • Image Analysis from Optical and Electron Microscopy
    • Quality
    • Case Studies
      • Analytical support into raw materials supplier qualification
      • Analytical investigation on OOS samples
      • Analytical investigation to support IP and regulatory procedures
      • Characterisation of nanostructures and nanoformulations
      • Comparison between development/test samples and Reference Drug Product/RLD samples
      • Image analysis studies from optical and electron microscopy
  • Contact us
Back to the gallery

News

DELOS FORMULATION TECHNOLOGY, THE BEST OPTION FOR YOUR NANOMEDICINES
15 November 2021

DELOS FORMULATION TECHNOLOGY, THE BEST OPTION FOR YOUR NANOMEDICINES

As the report in Farmaindustria magazine indicates, incremental innovation in medicines is a growing need, both for patients and healthcare professionals. This has the essential purpose of facilitating the use and efficacy of medicines, and, especially, of improving the quality of life of people. 

For this reason, drug reformulation technologies such as #DELOS are increasingly relevant in the sector. Incremental innovations are meeting an increasing demand and help in different aspects, which we could summarize in four: providing faster action, ease of use, and improvements in the efficacy and adherence of patients to their treatments. In addition, through incremental innovation, new routes of administration, and improvements in safety or dosage, can also be discovered, as well as the combination of two or more active ingredients that allow to use them more effectively. 

At Nanomol Technologies we have developed our own formulation technology called DELOS. #DELOS enables the development of advanced nanomedicines and tailored drug delivery systems. We are able to stabilize and improve the performance of #APIs, from small chemical molecules to biologics , including peptides, proteins and intracellular delivery of nucleic acids, of interest to our partners, enabling new routes of administration or improved drug products. 

If you are looking for an improvement in the formulation of your drug products, our technology can offer you many advantages in the market. 

Related
news

Stable nanovesicles formed by intrinsically planar bilayers 15 December 2022

Stable nanovesicles formed by intrinsically planar bilayers

Experts in particle characterization analysis 24 March 2022

Experts in particle characterization analysis

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug 28 February 2021

DELOS based nanoformulation for Fabry Disease designed as Orphan Drug

come and visit us

NANOMOL TECHNOLOGIES, S.L.
Mòdul de Recerca B
UAB CAMPUS

08193 Bellaterra
Cerdanyola del Vallès
Barcelona
Spain

get in touch

T +34 935 868 963
INFO@NANOMOL-TECH.COM

follow us

Twitter Linkedin

terms of use

Privacy policy Legality Cookies

Copyright © 2026

Nanomol Technologies S.L.

Site by Suki